Psilocybin for anhedonia in unipolar and bipolar depression: A systematic review of clinical and preclinical evidence.
BACKGROUND Anhedonia is a debilitating core feature of mood disorders, and is associated with significant functional impairment and poor quality of life. Psilocybin has recently emerged as a novel antidepressant treatment in major depressive disorder (MDD), however, its effects on anhedonia specifically have yet to be...